Skip to main content
. 2020 Jun 25;8(2):337. doi: 10.3390/vaccines8020337

Table 2.

Demographic characterization of study subjects.

Experiment Number of Subjects Gender Balance Age Range Mean Age Allergic Patients Non-Allergic Subjects
Figure 4, Figure 5, Figures S1 and S2 n = 12 m = 5, f = 7 26–46 (years) 32 (years) n = 2 n = 10
Figure 6 and Figure 7 n = 18 m = 9, f = 9 23–59 (years) 40.4 (years) n = 7 n = 11
Figure S3 n = 15 m = 7, f = 8 20–51 (years) 34.6 (years) n = 8 n = 7
Figure 8 n = 12 m = 8, f = 4 6–34 (months) 19 (months) unknown unknown